These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 34074012)

  • 1. Age-Related Alterations at Neuromuscular Junction: Role of Oxidative Stress and Epigenetic Modifications.
    Dobrowolny G; Barbiera A; Sica G; Scicchitano BM
    Cells; 2021 May; 10(6):. PubMed ID: 34074012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia.
    Xu H; Ranjit R; Richardson A; Van Remmen H
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1582-1596. PubMed ID: 34559475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Role of Lamin A/C in Preventing Neuromuscular Junction Decline in Mice.
    Gao N; Zhao K; Cao Y; Ren X; Jing H; Xing G; Xiong WC; Mei L
    J Neurosci; 2020 Sep; 40(38):7203-7215. PubMed ID: 32817327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
    Martineau É; Arbour D; Vallée J; Robitaille R
    J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular Junction Aging: A Role for Biomarkers and Exercise.
    Pratt J; De Vito G; Narici M; Boreham C
    J Gerontol A Biol Sci Med Sci; 2021 Mar; 76(4):576-585. PubMed ID: 32832976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species in sarcopenia: Should we focus on excess oxidative damage or defective redox signalling?
    Jackson MJ
    Mol Aspects Med; 2016 Aug; 50():33-40. PubMed ID: 27161871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular junction transmission failure in aging and sarcopenia: The nexus of the neurological and muscular systems.
    Arnold WD; Clark BC
    Ageing Res Rev; 2023 Aug; 89():101966. PubMed ID: 37270145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein aggregation causes muscle atrophy through neuromuscular junction degeneration.
    Yang Q; Wang Y; Zhao C; Pang S; Lu J; Chan P
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):226-242. PubMed ID: 36416282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging.
    Anagnostou ME; Hepple RT
    Cells; 2020 Jan; 9(1):. PubMed ID: 31941062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling and aging at the neuromuscular synapse: lessons learnt from neuromuscular diseases.
    Punga AR; Ruegg MA
    Curr Opin Pharmacol; 2012 Jun; 12(3):340-6. PubMed ID: 22365504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle Fibers Secrete FGFBP1 to Slow Degeneration of Neuromuscular Synapses during Aging and Progression of ALS.
    Taetzsch T; Tenga MJ; Valdez G
    J Neurosci; 2017 Jan; 37(1):70-82. PubMed ID: 28053031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared resistance to aging and ALS in neuromuscular junctions of specific muscles.
    Valdez G; Tapia JC; Lichtman JW; Fox MA; Sanes JR
    PLoS One; 2012; 7(4):e34640. PubMed ID: 22485182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of IGF-1 isoforms on muscle growth and sarcopenia.
    Ascenzi F; Barberi L; Dobrowolny G; Villa Nova Bacurau A; Nicoletti C; Rizzuto E; Rosenthal N; Scicchitano BM; Musarò A
    Aging Cell; 2019 Jun; 18(3):e12954. PubMed ID: 30953403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the causes of sarcopenia: Roles of neuromuscular junction impairment and mitochondrial dysfunction.
    Miao Y; Xie L; Song J; Cai X; Yang J; Ma X; Chen S; Xie P
    Physiol Rep; 2024 Jan; 12(1):e15917. PubMed ID: 38225199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic Sirt1 protects terminal Schwann cells and neuromuscular junctions from age-related morphological changes.
    Snyder-Warwick AK; Satoh A; Santosa KB; Imai SI; Jablonka-Shariff A
    Aging Cell; 2018 Aug; 17(4):e12776. PubMed ID: 29851253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia.
    Bütikofer L; Zurlinden A; Bolliger MF; Kunz B; Sonderegger P
    FASEB J; 2011 Dec; 25(12):4378-93. PubMed ID: 21885656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron specific reduction in CuZnSOD is not sufficient to initiate a full sarcopenia phenotype.
    Sataranatarajan K; Qaisar R; Davis C; Sakellariou GK; Vasilaki A; Zhang Y; Liu Y; Bhaskaran S; McArdle A; Jackson M; Brooks SV; Richardson A; Van Remmen H
    Redox Biol; 2015 Aug; 5():140-148. PubMed ID: 25917273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in muscle and neuromuscular junction morphology between atrophy-resistant and atrophy-prone muscles supports failed re-innervation in aging muscle atrophy.
    Burke SK; Fenton AI; Konokhova Y; Hepple RT
    Exp Gerontol; 2021 Dec; 156():111613. PubMed ID: 34740815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-induced gene expression changes in skeletal muscle of old mice.
    Endo Y; Zhang Y; Olumi S; Karvar M; Argawal S; Neppl RL; Sinha I
    Genomics; 2021 Sep; 113(5):2965-2976. PubMed ID: 34214629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related Differences in Dystrophin: Impact on Force Transfer Proteins, Membrane Integrity, and Neuromuscular Junction Stability.
    Hughes DC; Marcotte GR; Marshall AG; West DWD; Baehr LM; Wallace MA; Saleh PM; Bodine SC; Baar K
    J Gerontol A Biol Sci Med Sci; 2017 May; 72(5):640-648. PubMed ID: 27382038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.